Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : CAR-NK Cell Therapy
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Catamaran Bio
Deal Size : Undisclosed
Deal Type : Partnership
Details : The partnership will enable the development and manufacturing of Catamaran Bio’s allogeneic chimeric antigen receptor (CAR)-NK cell therapies for the treatment of solid tumors.
Brand Name : Undislcosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
March 14, 2023
Lead Product(s) : CAR-NK Cell Therapy
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Catamaran Bio
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?